Nemours Children's Health, Jacksonville Trial Shows That A Bionic Pancreas Improves Type 1 Diabetes Management Compared To Standard Insulin Delivery Methods
October 04, 2022
October 04, 2022
JACKSONVILLE, Florida, Oct. 4 (TNSjou) -- Nemours Children's Health System issued the following news release:
A device known as a bionic pancreas, which uses next-generation technology to automatically deliver insulin, was more effective at maintaining blood glucose (sugar) levels within normal range than standard-of-care management among people with type 1 diabetes, a new multicenter clinical trial has found. The trial, conducted partly at Nemours Children's Health, Jacks . . .
A device known as a bionic pancreas, which uses next-generation technology to automatically deliver insulin, was more effective at maintaining blood glucose (sugar) levels within normal range than standard-of-care management among people with type 1 diabetes, a new multicenter clinical trial has found. The trial, conducted partly at Nemours Children's Health, Jacks . . .